Translational Safety Biomarker Pipeline: Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease
As we are reaching the Project end, we would like to thank all Partners for their dedicated work over the last 6 years!
38 publications are just a small pict of the project impact on #biomarkers
👉 https://t.co/lDeamEy2jf
#IHICarryTheTorch#H2020#EUHealthResearch@IHIEurope
We're excited to announce that Sophia Samodelov, our Project Coordinator, will be a panelist at the upcoming “Advancing regulatory science research” event organised by @EMA on November 18!
Register by November 13
👉 https://t.co/sI5UuuL3oH
#biomarkers#H2020@IHIEurope
During last Cutting Edge Pathology Congress, Warren Glaab presented the results of nonclinical studies to support identification and qualification of biomarkers for early DINI
#IHICarryTheTorch#H2020#EUHealthResearch@IHIEurope